SPX4,207.34-2.90 -0.07%
DIA333.76+0.56 0.17%
IXIC12,779.91-74.89 -0.58%

Viking Therapeutics Q2 EPS $(0.23) Misses $(0.21) Estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 15 percent decrease over losses of $(0.20) per share from

Benzinga · 07/27/2022 16:37
Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 15 percent decrease over losses of $(0.20) per share from the same period last year.